Behind some of Australia’s most recognisable supplement brands stands a single family-owned manufacturer with a $220m expansion underway. Here, two generations share how conviction has built Vitex Pharmaceuticals into a global force, and what comes next
—by Carlie Trotter and Louis White.
On a stretch of industrial land in Sydney’s west, a $220m pharmaceutical manufacturing facility is nearing completion. The building on Wonderland Drive in Eastern Creek will house state-of-the-art production lines, an analytical laboratory, and the ambitions of a family that has spent nearly four decades testing the limits of what Australian manufacturing can achieve. When it opens later this year, the new factory will nearly treble the capacity of Vitex’s existing Eastern Creek site and take the company’s headcount from around 400 to close to 1200.
For Aniss Chami, the company’s chief executive, the Wonderland site represents something beyond mere expansion. “It’s not a replacement facility,” he says. “It’s additive. And what excites us most is being able to employ more people from western Sydney for a western Sydney business.”
With the implications for workforce growth and sovereign manufacturing capability, the launch is attracting attention from the highest levels of government.
The scale of the operation can be difficult to grasp.
Vitex is a contract manufacturer, the unseen hand behind many of Australia’s most trusted holistic health brands. Walk down the supplement aisle at your local chemist and you are almost certainly looking at their work: millions of units a month across hundreds of product lines. Yet the Chami name appears on none of them. “We are the suit tailor in the middle between the brand and the end user,” is how Lucie Chami, the company’s chief procurement officer, puts it. “Brands come to us with their concepts and we take them from formula to production to shelf.”
Today, Vitex is one of the largest privately held manufacturers in the sector, valued in the hundreds of millions, exporting directly to 26 countries and indirectly to around 80. Its capabilities span formulation, manufacturing, packaging and comprehensive regulatory support. The headquarter’s shelves are lined with products that never saw the light of day, many bearing names you could not imagine working on a local supermarket shelf. The ones that did make it, however, are in medicine cabinets across the globe.
The university of life
The story begins a long way from Sydney. Elie Chami grew up in Haql El Aazimeh, a small mountainous community in northern Lebanon defined more by self-sufficiency than ambition. Families worked the land and traded locally; it was an unlikely birthplace for a manufacturing dynasty.
When he arrived in Sydney in 1975, aged 16, Elie’s family depended on him to contribute immediately. “I was a good student back home,” he reflects, “but English wasn’t taught at school so when I got here I had to start from scratch.”
His early working life was varied: construction sites, delivery runs, even a stint as a driving instructor. Nights were spent at Newtown Technical College learning English. “They wanted to place me in a grade below my age,” he recalls. “I didn’t have that time. My father needed me.” His favourite slogan, often repeated to his children: “I went to the university of L-I-F-E.”
It was a return trip to Lebanon in 1981 that changed everything, and where he met Robine, who would become his wife. “People couldn’t easily access medicines or vitamins,” he says. “There were gaps. I started bringing vitamins in my suitcase and selling them.” Elie crisscrossed the Middle East—from Kuwait to Iraq to Jordan—up to four times a year, building the kind of market intelligence that can only be gathered on the ground.
The business began as a modest export operation in Sydney’s south-west, with Robine’s support proving indispensable while the children were young. By the late 1990s, the operation had shifted from buying and selling to manufacturing—a leap that Robine initially questioned. “She said ‘we don’t want to lose the money we’ve made, we don’t know how to manufacture medicine’,” Elie recalls. “I said ‘we’ll learn, even if we have to throw a couple of batches in the bin, you learn from what you throw away’.” Manufacturing commenced around 2000.
Strategic shores, sovereign ambition
The decision to manufacture locally rather than offshore was deliberate and, in the Australian context, relatively rare. While most holistic health brands source production from lower-cost markets, Elie bet early on the premium that ‘Australian-made’ commands internationally.
The regulatory framework is central to that advantage; Australia is one of very few countries that regulates
supplements as medicines under the Therapeutic Goods Administration to standards equivalent to prescription drugs. In the United States, by contrast, the same products Vitex manufactures in clinical-grade facilities could legally be made in a kitchen. “People in global markets know that about Australia,” Aniss observes, “and once they start trialling Australian-made medicines, they don’t go anywhere else.”
The timing has vindicated that bet. The global wellness economy reached a record US$6.8tn in 2024, according to the Global Wellness Institute, and is forecast to approach $10tn by 2029. Traditional and complementary medicine is projected as the second fastest-growing segment, expanding at 10.8 per cent annually. A broader cultural shift from reactive healthcare towards proactive wellness—consumers reaching for fish oil, magnesium and vitamin D before problems arise rather than after—has placed contract manufacturers like Vitex at the centre of an enormous structural tailwind.
“The advantage is sustainable,” Aniss suggests, “because other countries cannot easily up regulate without disrupting their local industries.” In investment terms, it is a genuine moat.
“People couldn’t easily access medicines or vitamins. There were gaps. I started bringing vitamins in my suitcase and selling them.”
Instinct and instrument
There is a saying in the industry, among those who know father and son well: ‘Elie is the heart, Aniss is the brains’. Aniss smiles at this. “We work in tandem. He has strengths that are not my strengths, and I have strengths that aren’t his. He’s the smartest guy in my books, but he knew when to give me the independence and autonomy to do what I do best.”
Lucie describes her father as “the Phoenician businessman” (the instinctive trader) and Aniss the Australian corporate strategist, the latter having sat on multiple peak bodies and become a conduit between industry and regulator. Yet for all his own credentials, Aniss is most struck by his father’s self-awareness. “I believe my father’s true power is insight into himself,” he says. “He knows where his limits are and he knows how to pass the baton so his vision is realised.
Aniss’s path to the CEO role was anything but conventional. He was nine when he first started in pick-and-pack, filling shippers with medicine alongside his father. He went on to train as a pharmacist, then a medical practitioner with a focus on surgery, accumulating seven tertiary qualifications including multiple business degrees. “I trained as a surgeon and loved learning about the intricacies of the human body,” he says. “But my father asked me to help scale Vitex. I realised I could impact thousands at a time. Medicine would still be a part of me, but this was an opportunity to apply those skills differently.”
His medical training has proved remarkably transferable. “A doctor knows how to gather information quickly, make decisions quickly, be empathic, respect diversity,” he says. “And because we’re a contract manufacturer, confidentiality is paramount—we can’t share one client’s ideas with another, even when both products are made on the same machine. Medicine taught me that discipline.”
Elie is characteristically direct about the handover; “I’m at the stage of handing over to them, and they want it. They tell me ‘relax, you’ve done more than we expected’.” Whether he can take that advice is another matter. “I just can’t sit down. Even if the spoon is halfway to your mouth at dinner and something about the business needs discussing, we discuss it.”
The barbecue test
For a family enterprise of this scale, the separation of personal and professional is not merely desirable but essential. All four Chami siblings hold senior operational roles, including Latify as chief operating officer and Anthony as chief of production. All hold MBAs alongside their respective specialisations. “We studied to strengthen our literacy across every facet of the business,” Aniss says. “We needed to speak like accountants to accountants, marketers to marketers, engineers to engineers.”
The governance architecture was shaped in part by external advisors, who delivered a formative piece of counsel when Aniss was first appointed chief executive. “They said, regardless of it being your brother, you respect the seat,” Lucie recalls. “If someone is in that chair, whether you agree with them or not, you respect them as your superior. That really struck a chord. It allowed the family to separate business and family like church and state.”
Aniss applies what he calls the ‘barbecue test’ to every leadership appointment, family or otherwise. “We can have a heated debate, I find that healthy,” he says. “But can we walk out of that room and have a barbecue together, knowing the argument was for the betterment of Vitex and not based on self-interest? That’s the attribute I value most.”
The presence of non-family executives in senior roles is a deliberate counterweight. “Non-family chiefs add a layer of sophistication and cooperation that is critical,” Lucie observes. “It allows us as siblings to walk outside our offices and put our corporate hats back on. This is big business now. It’s family culture in a corporation.”
Beyond her procurement role, Lucie manages the Chami family office, overseeing a substantial portfolio of residential, commercial and industrial properties. “I was put into that role because I share a lot of my father’s characteristics,” she reflects. “He had goals for the family office and I was best placed to fulfil them.” It is a weighty brief, but Lucie frames it as privilege rather than burden. “Dad is very candid about passing this on to future generations. It’s incredible to watch him give so much of his life to pave the way for us, in the hope that we do the same for our children. That’s what drives me, this is his and our legacy.”
Off the clock
Elie spends his downtime mapping out the gardens of the
family’s Dural homestead with the same forensic attention he brings to the factory floor. “If the guy doing the hedging misses an area, I’ll say: why? It must be in line,” he says. “If I can see it, you should see it.” Nothing waits until tomorrow. He is a self-described social person who travels widely and delights in his 12 grandchildren, while conceding that full retirement will never come. His life story is now being chronicled in an Arabic-language biography.
Lucie, who juggles her Vitex role, the family office and four children under seven, is candid about the intensity of this particular chapter. “When I leave here I pick up my kids, we do the routine and everything else is on pause,” she says. “My job is complex and challenging, but it’s highly rewarding. It’s the same principle.” The satisfaction she draws from each responsibility is immediate and tangible.
Aniss describes 2025 as a milestone year he would rather not repeat. A new baby at home and Wonderland under construction while existing sites ran at record production volumes—none of it possible, he and Lucie both stress, without the siblings who keep the operation turning daily. “Latify and Anthony: this place does not turn on without them,” says Lucie. “The cogs in the wheel are turned by them every single day.” For Aniss, the resilience required is a family trait. “True success for me is not measured by being able to succeed, it’s being able to overcome a challenge and applying what you learn to better yourself and those around you.”
Beyond the formula
Elie was recently awarded an honorary doctorate by Western Sydney University for his contributions to business and manufacturing. “I was shocked and honoured,” he says. Aniss, meanwhile, received a global leadership award from CEO Today magazine. But this is not a family given to resting on accolades.
The conversation around legacy has already shifted to the generation after next. The Chami siblings are conscious that their children will inherit a very different foundation from the one they themselves were handed. “When we joined the business, it was hard,” Lucie recalls. “Financial pressure. Sinking or swimming. You had to be thick-skinned. But looking at the next generation, the directive is different. It’s about critical thinking. How do they add value? How do they improve upon what’s being given to them?” Elie’s own vision for legacy is unsurprisingly concrete.
Building the frontier
The Wonderland facility extends well beyond additional capacity. It diversifies Vitex’s capabilities into registered medicines—on top of the listed complementary medicines that have been its mainstay—as well as new dosage and packaging formats. The R&D operation employs more than 120 people, testing and refining formulations, ensuring stability across shelf life and developing new delivery systems for overseas markets.
Aniss is nuanced about technology’s role. “For me, technology is a double-edged sword,” he says. “Automation creates phenomenal efficiencies, but it can also replace the traditional processes that make us inimitable. We never use technology to replace what we’re good at—only to make us more efficient, more accurate, more streamlined.” Vitex buys only new-generation equipment for every new site, never second-hand or transferred. “Pharmaceutical equipment is built to last decades,” he notes. “But we’re fortunate that we can always invest in the latest.”
And then there is the fish oil venture. The family holds a stake in AO3 Pty Ltd, which is developing the country’s first commercial-scale fish oil refinery for pharmaceutical-grade product, entirely Australian-caught and Australian-refined. Elie’s logic was simple: why import fish oil from Norway and China when we have one of the longest coastlines in the world? The startup secured a government catch quota and is expected to come online around the same time as Wonderland. Elie is already eyeing a site in Western Australia for a second refinery. His brain, as those around him observe, is forever ticking over.
“You can go to university to be a doctor, a nurse, a pharmacist, but there is nowhere to learn how to make the medicines [at commercial scale]. Every person who has come into Vitex, we’ve trained from scratch. I want to do that for the whole country.”
He is working with the Western Sydney Aerotropolis innovation precinct to establish a training institute bearing his name focused on the practical craft of manufacturing medicines at scale. There is, he points out, no dedicated training centre in Australia for pharmaceutics and
pharmaceutical process engineering. “You can go to university to be a doctor, a nurse, a pharmacist, but there is nowhere to learn how to manufacture the medicines [at commercial scale],” he says. “Every person who has come into Vitex, we’ve trained from scratch. I want to do that for the whole country.”
The long game
The family’s collective ambition is expansive but precise. “We want Vitex to be a top-five global manufacturer in complementary medicines,” Aniss says. “Our products are world-class. We will continue innovating.” The principles guiding that push, he makes clear, are the same ones his father instilled: integrity, quality, and a refusal to cut corners.
It is Lucie who best captures the pull of the family enterprise. “I thought my path after university would be to work for a large conglomerate and sort of work my way up,” she says. “But Dad asked me once: why would you go and build up Coca-Cola when you could be building the family business for yourself and your children? An office was already fitted out, ready for my graduation date. I have never questioned it since.”
From a suitcase of vitamins to a multimillion-dollar operation exporting to 80 countries, Elie Chami has spent his life reading signs that others did not notice. Now with a new factory rising, a refinery taking shape up the road and a training institute on the drawing board, the compound effect of one family’s conviction is becoming difficult to ignore.